Sort   by:  
 Page size 
UnknownClinical course of light-chain smouldering multiple myeloma (idiopathic Bence Jones proteinuria): a retrospective cohort study.
Not available
S-EPMC4266993 | biostudies-literature
UnknownA randomized phase 3 study of ixazomib-dexamethasone versus physician's choice in relapsed or refractory AL amyloidosis.
Not available
S-EPMC8727292 | biostudies-literature
UnknownA validated composite organ and hematologic response model for early assessment of treatment outcomes in light chain amyloidosis.
Not available
S-EPMC7156647 | biostudies-literature
UnknownVenetoclax induced a complete response in a patient with immunoglobulin light chain amyloidosis plateaued on cyclophosphamide, bortezomib and dexamethasone.
Not available
S-EPMC5830371 | biostudies-literature
UnknownA phase 1/2 study of the oral proteasome inhibitor ixazomib in relapsed or refractory AL amyloidosis.
Not available
S-EPMC6911836 | biostudies-literature
UnknownContinuous lenalidomide and low-dose dexamethasone in patients with transplant-ineligible newly diagnosed MM: FIRST trial subanalysis of Canadian/US patients.
Not available
S-EPMC7724300 | biostudies-literature
UnknownNovel Type of Renal Amyloidosis Derived from Apolipoprotein-CII.
Not available
S-EPMC5280007 | biostudies-literature
UnknownFuture Perspectives.
Not available
S-EPMC7576440 | biostudies-literature
UnknownPOEMS syndrome in the 21st century: A bibliometric analysis.
Not available
S-EPMC10570589 | biostudies-literature
UnknownLight-chain cardiac amyloidosis: strategies to promote early diagnosis and cardiac response.
Not available
S-EPMC5566095 | biostudies-literature
Sort   by:  
 Page size